Loghman Pharmaceutical Trades Below the Drug Sector, but Its Half-Year Profit Has Not Yet Reached the Bank (Sunday 22 November 2026)
Sahmino Research Desk | 22 November 2026 | Short | 00:42
Watch onSahmino
Loghman Pharmaceutical & Hygienic (DLGM) closed at 10,910 rials on 22 November 2026, a P/E of 7.35 against 11.45 for the drug sector. Audited six-month net profit was 12,104 billion rials, 3.6 times a year earlier and above all of fiscal 1404, but operating cash flow was minus 6,016 billion rials and receivables rose 79%. October sales beat the…
Related videos
Auditor signs off: Khorasan Petrochemical earned more in six months than in all of last year (Saturday 21 November 2026)
Short | 00:36StocksThe PLSH Refinery Fund Still Trades 26% Below Its Net Asset Value, a Discount That Has Narrowed Since September (Friday 20 November 2026)
Short | 00:38StocksPrice, Not Tonnage: NALM Sold Less Aluminium Over Seven Months Yet More Than Doubled Its Sales (Thursday 19 November 2026)
Short | 00:36StocksSelling Its Persian Gulf Petrochemical Stake Gives Shiraz Petrochemical a 183 Trillion Rial Book Gain, More Than All of Its 1404 Net Profit (Tuesday, 17 November 2026)
Short | 00:31Stocks




